Acorah Software Products - Accounts Production 16.8.200 false true 30 April 2024 1 May 2023 false true No description of principal activity 1 May 2024 30 April 2025 30 April 2025 12561460 Mr Emal Bakhshi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12561460 2024-04-30 12561460 2025-04-30 12561460 2024-05-01 2025-04-30 12561460 frs-core:CurrentFinancialInstruments 2025-04-30 12561460 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 12561460 frs-bus:FilletedAccounts 2024-05-01 2025-04-30 12561460 frs-bus:Micro-entities 2024-05-01 2025-04-30 12561460 frs-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 12561460 frs-bus:Director1 2024-05-01 2025-04-30 12561460 frs-bus:Director1 2024-04-30 12561460 frs-bus:Director1 2025-04-30 12561460 2023-04-30 12561460 2024-04-30 12561460 2023-05-01 2024-04-30 12561460 frs-core:CurrentFinancialInstruments 2024-04-30
Registered number: 12561460
e Bakhshi Pharm Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2025
Y&H Consulting ltd
e Bakhshi Pharm Ltd
Balance Sheet
As At 30 April 2025
Balance Sheet
Registered number: 12561460

| 2025 | 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 2,451 | 428
Current assets |  | 16,599 | 32,770
Creditors: Amounts Falling Due Within One Year |  | (18,143 ) | (33,189 )
NET CURRENT LIABILITIES |  | (1,544 ) | (419 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 907 | 9
Accruals and deferred income |  | (900 ) | -
NET ASSETS |  | 7 | 9
CAPITAL AND RESERVES |  | 7 | 9

## Notes

1. General Information
e Bakhshi Pharm Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12561460 . The registered office is Flat 18 Lyne Court, Church Lane, London, England, NW9 8LE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:

| As at 1 May 2024 | Amounts advanced | Amounts repaid | Amounts written off | As at 30 April 2025
--- | --- | --- | --- | --- | ---
| £ | £ | £ | £ | £
Mr Emal Bakhshi | (30,487 ) | (26,466 ) | 43,454 | - | (13,499 )

The above loan is unsecured, interest free and repayable on demand.
Page 0
Page 1
e Bakhshi Pharm Ltd
Balance Sheet (continued)
As At 30 April 2025
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr Emal Bakhshi Director
22/01/2026